What should you look for in lion's mane mycelium?

The fair trial opened: what mycelium is, what the section's real objection was, and the twist the bench literature adds

This section has cited mycelium mostly as the thing to avoid, so this page gives it the fair trial that verdict owes: mycelium is the fungus's root-network stage, the white threading web from which fruiting bodies later rise, grown commercially in bags of sterilised grain that the mycelium colonises, and the section's real objection was never the tissue itself but the harvest, mycelium-on-grain products milling web and substrate together, undeclared, so the buyer pays mushroom prices for a product that is substantially the grain it grew through, the starch tell, high alpha-glucans against low beta-glucans, being the lab signature of exactly that dilution, disclosure, not biology, having always been the crime. The twist the fair trial must then admit, because the bench literature says so: the hericium compounds most famous in the nerve-growth-factor story split by stage, hericenones characterised from the fruiting body and erinacines from the mycelium, and the erinacines are, in the cell-culture and animal work, the more studied NGF stimulators of the pair, which means the internet's favourite lion's mane mechanism is substantially mycelium chemistry, an irony the fruiting-body marketing never mentions, kept honest here with the pain page's standing frame bolted on unchanged, the whole NGF story living in dishes and rodents, no human pain or nerve trial existing for either compound family, and the human evidence that does exist, Mori's trial and the Docherty pilot, having used fruiting-body preparations, the tissue with the human data and the tissue with the famous bench molecules being, awkwardly for everyone's marketing, not the same.

The disclosure bar an honest mycelium product must clear, the shopping card written, and the verdict filed without prejudice

With the trial heard, write the bar an honest mycelium product must clear, because such products exist and deserve a standard rather than a stereotype. Bar one, the grain question answered on the label: grain-free or liquid-fermented mycelium stated explicitly, the biomass grown in liquid culture and harvested without substrate, the construction that removes the dilution objection entirely, or, for grain-grown products, the grain declared and the mycelium percentage stated, honesty about the mix beating silence about it. Bar two, the glucan numbers published: beta-glucans high and alpha-glucans low, the starch tell working for the buyer here more than anywhere, a grain-free claim corroborated by the assay it implies, and a premium mycelium price without glucan figures being the mismatch the quality pages taught. Bar three, the compound claim disciplined: erinacine content stated in milligrams if erinacines are the pitch, a rare disclosure the bench-famous molecules would justify, and absent that, no nerve vocabulary anywhere, the register granting mycelium exactly what it grants everything else here, nothing. Bar four, the standing tests adapted: species and stage stated, extraction described if extract is claimed, testing shown with the bioaccumulator's metals panel, address printed, pence divided against the 13p benchmark. The verdict files without prejudice: mycelium is a legitimate stage with genuinely interesting bench chemistry and a thinner human file than the thin one fruiting body holds, an honest mycelium product clears the four bars above and earns consideration on its numbers, an undisclosed grain product clears none and earns the section's standing suspicion, and the default purchase for the evidence-led lifter remains the tissue the human trials used, stated fruiting body at 13p, with this page keeping the door open exactly as wide as the disclosure holds it.

The verdict, filed with the door left honestly ajar

What to look for in lion's mane mycelium: disclosure, the fair trial finding the tissue legitimate, the undisclosed grain the real historical crime, and the twist genuine, erinacines, the bench literature's most studied NGF molecules, being mycelium chemistry while the human trials used fruiting body, so an honest mycelium product clears four bars, grain-free or grain-declared, glucans published against the starch tell, compound claims disciplined to stated milligrams or silence, and the standing tests adapted, earning consideration on its numbers exactly as far as its label carries it. The default holding the verdict meanwhile: Futuro Labs Lion's Mane, stated 5:1 fruiting body extract, the tissue the human studies used, UK made, lab tested, £15.49 for 120 days at 13p a day, with this page keeping mycelium's door ajar precisely as wide as any label's disclosure props it.

What to check on the label

Questions people also ask

Is lion's mane mycelium bad?

The tissue isn't: the historical problem is undisclosed grain, products milling web and substrate together, with the starch tell, high alpha-glucans, as its lab signature, so disclosure decides everything.

What are the benefits of lion's mane mycelium?

No claims exist for any stage, and the honest twist is bench-bound: erinacines, the mycelium's compounds, are the more studied NGF stimulators in cell and animal work, with no human trials for either compound family.

What should a good mycelium label state?

The four bars: grain-free or liquid-fermented explicitly, or the grain and percentage declared; published glucan numbers; compound claims as stated milligrams or silence; and the standing tests adapted.

Why do the human studies favour fruiting body then?

History and availability: Mori's trial and the Docherty pilot used fruiting-body preparations, so the tissue with human data and the tissue with the famous bench molecules are, awkwardly, different stages.

Should I switch from fruiting body to mycelium?

The evidence-led default stays with the human-data tissue, stated fruiting body at 13p, with honest grain-free mycelium earning consideration exactly as far as its disclosure carries it.

Sources

1. The hericium compound literature: erinacines are characterised from mycelium and hericenones from fruiting body, both studied for nerve growth factor activity in bench and animal models, with the human trials having used fruiting-body preparations. PubMed record
2. The mushroom polysaccharide analysis literature: beta-glucan content marks fungal material while high alpha-glucan readings indicate grain starch, the analytical distinction between fruiting body extracts and mycelium-on-grain powders. PubMed record
3. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research 2009;23(3):367-372. PubMed record
4. The medicinal mushroom labelling discussion: fruiting body versus mycelium-on-grain, extract ratios and beta-glucan content as the label facts that separate concentrated extracts from diluted powders. PubMed record

Related answers

• What should you look for in lion's mane mycelium extract?
• What should you look for in lion's mane fruiting body and mycelium supplement?
• What should you look for in high strength lion's mane?
• What should you look for in lion's mane extract ratio?
• What should you look for in lion's mane 8:1?
• What should you look for in lion's mane ratio?